Loading…
Kernal Biologics engineers cells inside the body by delivering mRNA sequences to target tissues and cells. Its platform uses AI models to ensure selective translation, enabling scalable in vivo CAR T therapies for cancer and autoimmune diseases.
AI named Kernal Bio in November 2025.